Articles
Reformulating an asthma drug for inhalation
Invion and Hovione Scientia will partner on the development of inhaled INV104 (zafirlukast) as a potential new treatment for asthma. INV104 is a leukotriene receptor antagonist which works by blocking the action of leukotrienes in the lungs, thereby preventing inflammation and narrowing of the airways. [ + ]
Rheumatoid arthritis and heart valve disease link
The overproduction of an inflammatory protein that causes rheumatoid arthritis has also been implicated in the development of heart valve disease. [ + ]
Governments shouldn't be able to censor research results they don't like
Governments often impose legal conditions on such research that can subvert science and the public interest. [ + ]
Two giant leaps for mankind
It's been an exciting couple of weeks in the field of astronomy, with scientists both discovering new worlds and finding out more about old ones. [ + ]
Orthocell regenerates cartilage within joints
An international research paper provides peer-reviewed support for Orthocell's new approach to the regeneration of damaged cartilage within joints. [ + ]
The pharmaceutical scientist
Professor Patrick Sexton, head of the Drug Discovery Biology theme at the Monash Institute of Pharmaceutical Science, reflects on a research career in pharmacology and how working within a large research program that encompasses translational drug discovery, drug delivery and drug development has enriched his team's research. [ + ]
AstraZeneca and Adelaide collaborate on drug discovery
AstraZeneca's agreement with Adelaide Research and Innovation will provide an opportunity for researchers at the University of Adelaide to collaborate with industry-leading scientists to develop new medicines. [ + ]
Hormonal traders make risky decisions
A new study has found that the state of a trader's body chemistry can impact the stock market just as much as the state of the economy. [ + ]
Spinifex Pharmaceuticals sold to Novartis
Australian biotech Spinifex Pharmaceuticals will be bought by global healthcare company Novartis for US$200 million. [ + ]
The drive for connected labs in pharmaceutical QA/QC
Few QA/QC labs still cling to the old paper-based notebook systems of the past, but there's far more to becoming a paperless lab than simply eschewing paper. [ + ]
Superbug genome successfully decoded
Researchers have completed the first large-scale study that uses genomic technology to decode the genes of the bacterium Klebsiella pneumoniae (KP). [ + ]
Get inside the head of a T. rex
Exclusive computed tomography (CT) images reveal an in-depth look at one of the best preserved Tyrannosaurus rex skulls ever found. [ + ]
3D-printed jaw implant a first
Designed and made in Australia, a 3D-printed prosthetic jaw joint has been successfully used in reconstructive surgery. [ + ]
Controlling stem cell behaviour can stop the spread of bowel cancer
The spread of bowel cancer can be stopped by targeting dormant bowel cancer cells before they form secondary tumours. [ + ]
The sky's the limit: construction approved for the Giant Magellan Telescope
June 2015 marked a major milestone in the field of astronomy, with construction approval announced for the highly anticipated Giant Magellan Telescope — the biggest optical telescope in the world. [ + ]